Clinical trials have reported gastrointestinal side effects as common adverse events with incretin-based therapies, including nausea and vomiting, which may affect patient adherence
The expansion of Medicare coverage for semaglutide has meaningfully expanded this population
Tesamorelin may be discussed with eligible adults who are looking for provider-guided care related to body composition, hormone optimization, healthy aging, or specific medical indications such as HIV-associated lipodystrophy
High research engagement has not yet translated into broad patient access, making Japan a market to watch rather than a market already lets have a bolder moving
Tablet formulations use absorption enhancers to survive the digestive tract, with FDA-approved oral semaglutide (Rybelsus) available for daily tablet dosing
The warmth accelerates the gastrocolic reflex more than cold water does